ICAHN CARL C
Institutional investor · Portfolio as of Q1 2023
Top Holdings17 positions
ICAHN ENTERPRISES LP | 300M | $15.5B | 70.4% | $16.20 | +46.35% | 18 qtrssince 2018-Q4 | Unchanged 0 |
CVR ENERGY INC | 71.2M | $2.3B | 10.6% | $19.52 | +39.53% | 18 qtrssince 2018-Q4 | Unchanged 0 |
FirstEnergy Corp | 19M | $759.8M | 3.4% | $28.13 | +24.17% | 9 qtrssince 2021-Q1 | Unchanged 0 |
| 16.5M | $675.9M | 3.1% | — | — | — | Increased 61 | |
Southwest Gas Holdings Inc | 10.5M | $657M | 3.0% | $62.45 | -9.49% | 7 qtrssince 2021-Q3 | Increased 81 |
Xerox Holdings Corp | 34.2M | $527.4M | 2.4% | $15.72 | -21.18% | 5 qtrssince 2022-Q1 | Unchanged 0 |
Newell Brands Inc | 30M | $373M | 1.7% | $13.04 | -17.80% | 18 qtrssince 2018-Q4 | Decreased 0 |
Valeant Pharmaceuticals Intern | 34.7M | $281.2M | 1.3% | $29.39 | -73.76% | 10 qtrssince 2020-Q4 | Unchanged 0 |
Dana Inc | 14.3M | $215M | 1.0% | $20.31 | -33.48% | 10 qtrssince 2020-Q4 | Unchanged 0 |
Cheniere Energy Inc | 1M | $157.6M | 0.7% | $55.31 | +402.92% | 18 qtrssince 2018-Q4 | Unchanged 0 |
Conduent Inc | 38.1M | $130.9M | 0.6% | $9.55 | -64.83% | 18 qtrssince 2018-Q4 | Unchanged 0 |
Illumina Inc | 430,000 | $100M | 0.5% | $219.12 | 0.00% | 1 qtr | New 53 |
Crown Holdings Inc | 1M | $86M | 0.4% | $77.38 | +2.11% | 3 qtrssince 2022-Q3 | Unchanged 0 |
SandRidge Energy Inc | 4.8M | $69.4M | 0.3% | $5.53 | +87.16% | 18 qtrssince 2018-Q4 | Unchanged 0 |
Bausch Lomb Corp | 3.5M | $60.9M | 0.3% | $15.28 | +11.58% | 4 qtrssince 2022-Q2 | Unchanged 0 |
International Flavors & Fragra | 644,510 | $59.3M | 0.3% | $116.34 | -27.65% | 5 qtrssince 2022-Q1 | Unchanged 0 |
HERTZ GLOBAL HOLDINGS INC | 230,160 | $26.2M | 0.1% | $23.61 | +422.91% | 18 qtrssince 2018-Q4 | Decreased 0 |
ICAHN CARL C manages $22B across 17 positions as of Q1 2023. Top holdings: IEP (70.4%), CVI (10.6%), FE (3.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Added 1 new position, increased 2, trimmed 2. Top move: SWX (INCREASED, conviction 81). Portfolio: $22.0B across 17 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR